{"title":"Vaccine approved for shingles in older people.","authors":"","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>A new vaccine called Zostavax is available to reduce the risk of shingles (herpes zoster) in people ages 60 and older.</p>","PeriodicalId":76907,"journal":{"name":"FDA consumer","volume":"40 5","pages":"38-9"},"PeriodicalIF":0.0000,"publicationDate":"2006-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"FDA consumer","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
A new vaccine called Zostavax is available to reduce the risk of shingles (herpes zoster) in people ages 60 and older.